Enhanced Anti-Mycobacterium tuberculosis Immunity over Time with Combined Drug and Immunotherapy Treatment

Enhanced Anti-Mycobacterium tuberculosis Immunity over Time with Combined Drug and Immunotherapy Treatment

It is estimated that one third of the world’s population is infected with Mycobacterium tuberculosis (Mtb). This astounding statistic, in combination with costly and lengthy treatment regimens make the development of therapeutic vaccines paramount for controlling the global burden of tuber...

Full description

Bibliographic Details
Main Authors: Sasha E. Larsen, Susan L. Baldwin, Mark T. Orr, Valerie A. Reese, Tiffany Pecor, Brian Granger, Natasha Dubois Cauwelaert, Brendan K. Podell, Rhea N. Coler
Format: Article
Language:English
Published: MDPI AG 2018-05-01
Series:Vaccines
Subjects:
therapeutic vaccine
Mycobacterium tuberculosis
tuberculosis
immunotherapy
adjuvant
GLA-SE
ID93
Online Access:http://www.mdpi.com/2076-393X/6/2/30

Similar Items

Similar Items